GSK-201532

Study Sponsor: GSK

Study Title

Evaluation of immunogenicity, safety and reactogenicity of GSK Biologicals’ dTpa booster vaccine (263855) (Boostrix) administered as a booster dose in healthy Russian subjects

Medicine or Vaccine (generic name)

Combined Reduced Antigen Content Diphtheria, Tetanus, Acellular Pertussis Vaccine

Sponsor Identification Number

201532

Trial Registry Identification Number(#'s)

NCT03311659 2015-003405-42

Medical Condition

Diphtheria; Tetanus; Acellular pertussis

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=201532

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03311659

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2015-003405-42

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

September 2020